Teladoc Health, Inc. (TDOC) Stock Forecast
TDOC analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.48 / 5 from 23 analysts
- Price target
- $7.59 average of analyst targets
- Upside to target
- +33.8% from the latest close
- Next earnings
- October 28, 2026 EPS estimate $-0.23
- 52-week range
- $4.47 – $9.72
TDOC analyst ratings
23 analystsNumber of analysts at each rating.
TDOC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
TDOC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.19 | −$0.23 | −$0.15 | −$0.19 | +0.6% | 3 |
| Current fiscal year (2026) | −$0.79 | −$0.99 | −$0.66 | −$0.66 | −19.9% | 3 |
| Next fiscal year (2027) | −$0.72 | −$1.02 | −$0.55 | −$0.79 | +8.1% | 3 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
TDOC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $592.3M | $571.8M | $628.0M | −5.5% | 20 |
| Current fiscal year (2026) | $2.42B | $2.36B | $2.52B | −4.3% | 21 |
| Next fiscal year (2027) | $2.40B | $2.21B | $2.57B | −1.0% | 21 |
TDOC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
TDOC revenue: reported and forecast
TDOC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.17 | −$0.20 | −$0.20 | −$0.20 | −$0.19 | +7.7% | 0 up · 2 down |
| Current fiscal year (2026) | −$0.79 | −$0.78 | −$0.78 | −$0.78 | −$0.79 | −0.1% | 1 up · 2 down |
| Next fiscal year (2027) | −$0.65 | −$0.79 | −$0.79 | −$0.79 | −$0.72 | +11.7% | 1 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
TDOC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; TDOC beat in 12 of 12.
What analysts expect from TDOC
23 analysts cover Teladoc Health; their consensus rating is hold (3.48 on a 1–5 scale, where 5 is a strong buy). The average price target is $7.59, 33.8% above the latest close of $5.67. Analysts expect earnings of −$0.79 per share for 2026, −19.9% from a year earlier. For 2027 the average estimate is −$0.72 per share on revenue of $2.4 billion. Teladoc Health beat the EPS estimate in 12 of the last 12 quarters.
Related: TDOC income statement, TDOC key metrics, TDOC chart. See the TDOC stock overview for the latest quote and news.
TDOC forecast FAQ
What is Teladoc Health's price target?
The average analyst price target for Teladoc Health is $7.59, 33.8% above the latest close of $5.67.
Is Teladoc Health a buy, hold or sell?
Of 23 analysts covering Teladoc Health, 5 rate it a strong buy, 1 a buy, 17 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Teladoc Health's EPS forecast?
Analysts forecast −$0.79 per share for 2026 (range −$0.99 to −$0.66); for 2027 the estimate is −$0.72.
What is Teladoc Health's revenue forecast?
The average revenue estimate for 2026 is $2.4 billion, growth of −4.3%; for 2027 it is $2.4 billion.
When does Teladoc Health report earnings?
Teladoc Health is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 after the market closes; the EPS estimate is $-0.23.
Does Teladoc Health usually beat earnings estimates?
Teladoc Health reported EPS at or above the analyst estimate in 12 of the last 12 quarters.